Novartis AG Profit Margin

Novartis AG (NVS) currently reports a profit margin of 17.89% as of September 2026. That compares with 25.63% in the prior-year period — down 30.2% year over year. That is below the Healthcare sector average of 19.13%. Use the charts on this page to explore Novartis AG's profit margin history and peer comparisons.

Novartis AG's profit margin decreased from 25.63% to 17.89% — a 30.2% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Novartis AG's profit margin of 17.89% is lower than the Healthcare sector average of 19.13%. That is roughly 6.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Novartis AG's current 17.89% should be judged against Healthcare norms (sector average: 19.13%) and against NVS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 17.89%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 19.13%. From there, open related valuation or income-statement pages for Novartis AG, and consider following NVS for alerts when major investors trade the stock.